WELCOME TO MEDSHADOW. WE'VE UPDATED OUR LOOK!

Quick Hits: Cryotherapy Risks & More

Cryotherapy Risks
Cryotherapy Risks

Quick Hits: Controversy surrounding the issue of whole-body cryotherapy in spas and gyms became more intense after a 71-year-old man suffered from stinging pain and redness resulting in blisters when a nozzle malfunctioned. Whole-body cryotherapy is on the rise as a new health trend, although not backed by scientific evidence and not approved by the FDA. Cryotherapy is generally used for small dermatological procedures such as freezing off a wart, but the whole-body version has been promoted as an aid for sore muscles, back pain and skin problems, among other issues. The treatment involves submerging the body (from the neck down) in a liquid nitrogen mist at temperatures ranging from -150 degrees F to -220 degrees F (-100 C to -140 C) for several minutes. Posted January 1, 2019. Via Reuters.

Quick Hits: Aurobindo Pharma USA has voluntarily recalled 80 lots of Amlodipine Valsartan, a blood pressure and heart failure medication. Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP have all been removed from the consumer-level of sale. Trace amounts of N-nitrosodiethylamine (NDEA), a known carcinogen, were detected in the tablets, possibly due to a manufacturing error. While NDEA can be found in certain foods, drinking waters and forms of pollution, it is still dangerous to the public. The FDA recommends that patients currently using the medication not stop taking it without a viable substitute, as this could cause more danger than the medication itself. Posted December 31, 2018. Via FDA.

Quick Hits: The French equivalent of the FDA, the National Agency for Medicines and Health Products Safety, has asked Allergan to voluntarily recall its line of textured breast implants due to increasing reports of leakage linked to a type of non-Hodgkin’s lymphoma called breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Textured breast implants make up 85% of the French market and are used for both cosmetic and reconstructive surgeries. So far, over 600 cases of BIA-ALCL have been reported worldwide, and 16 women have died. Sales have already been suspended in 33 countries due to the company’s failure to meet European Union health, safety and environmental standards. In the US, the FDA issued a statement saying: “We have been in contact with French regulatory authorities to discuss the issue.” The agency is meeting in 2019 to review the safety of all breast implants.Posted December 18, 2018. Via NBC News.

DISCLAIMER: MedShadow provides information and resources related to medications, their effects, and potential side effects. However, it is important to note that we are not a substitute for professional medical advice, diagnosis, or treatment. The content on our site is intended for educational and informational purposes only. Individuals dealing with medical conditions or symptoms should seek guidance from a licensed healthcare professional, such as a physician or pharmacist, who can provide personalized medical advice tailored to their specific circumstances.

While we strive to ensure the accuracy and reliability of the information presented on MedShadow, we cannot guarantee its completeness or suitability for any particular individual's medical needs. Therefore, we strongly encourage users to consult with qualified healthcare professionals regarding any health-related concerns or decisions. By accessing and using MedShadow, you acknowledge and agree that the information provided on the site is not a substitute for professional medical advice and that you should always consult with a qualified healthcare provider for any medical concerns.

Was This Article Helpful?

Show Comments (0)
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x